ArticleThe European respiratory journal2020

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network.

Silke van Koningsbruggen-Rietschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.